Cargando…

Monitoring of Enoxaparin during Hemodialysis Covered by Regional Citrate Anticoagulation in Acute Kidney Injury: A Prospective Cohort Study

Background: Current guidelines recommend the monitoring of anti-factor Xa (anti-Xa) levels to avoid an accumulation of low-molecular-weight heparins in patients with acute kidney injury, but there is no evidence on how to proceed with such monitoring during continuous renal replacement therapy. Agai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wiegele, Marion, Adelmann, Dieter, Dibiasi, Christoph, Pausch, Andrè, Baierl, Andreas, Schaden, Eva
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509597/ https://www.ncbi.nlm.nih.gov/pubmed/34640507 http://dx.doi.org/10.3390/jcm10194491

Ejemplares similares

Anti-factor Xa Activity Is Not Associated With Venous Thromboembolism in Critically Ill Patients Receiving Enoxaparin for Thromboprophylaxis: A Retrospective Observational Study
por: Dibiasi, Christoph, et al.
Publicado: (2022)

Thrombin Generation and Platelet Function in ICU Patients Undergoing CVVHD Using Regional Citrate Anticoagulation
por: Wiegele, Marion, et al.
Publicado: (2021)

Subcutaneous Enoxaparin for Systemic Anticoagulation of COVID-19 Patients During Extracorporeal Life Support
por: Wiegele, Marion, et al.
Publicado: (2022)

Low molecular weight heparin versus unfractioned heparin for anticoagulation during perioperative extracorporeal membrane oxygenation: A single center experience in 102 lung transplant patients
por: Gratz, Johannes, et al.
Publicado: (2020)

Heparin-induced thrombocytopenia in a non-heparin-naive patient: a case report
por: Wiegele, Marion, et al.
Publicado: (2015)

Comparison of the New Viscoelastic Coagulation Analyzer ClotPro® With ROTEM® Delta and Conventional Coagulation Tests in Critically Ill Patients With COVID-19
por: Infanger, Lukas, et al.
Publicado: (2021)

Regional Citrate Anticoagulation for Intermittent Hemodialysis in Dogs
por: Francey, T., et al.
Publicado: (2017)

Regional citrate anticoagulation in high-volume continuous venovenous hemodialysis
por: Kalb, R, et al.
Publicado: (2011)

Double Pump Sequential Constant Citrate Anticoagulation in General Hemodialysis
por: Tang, Li, et al.
Publicado: (2022)

Diagnostic and therapeutic approach in adult patients with traumatic brain injury receiving oral anticoagulant therapy: an Austrian interdisciplinary consensus statement
por: Wiegele, Marion, et al.
Publicado: (2019)

Regional citrate anticoagulation for intermittent hemodialysis in the intensive care: what is the optimal setup?
por: Gubensek, Jakob, et al.
Publicado: (2021)

Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study
por: Slowinski, Torsten, et al.
Publicado: (2015)

Comparison of ROTEM parameters from venous and intraosseous blood
por: Wiegele, Marion, et al.
Publicado: (2019)

Quality indicators in prolonged hemodialysis with regional citrate anticoagulation with the genius system: retrospective cohort of critical patients with acute kidney injury
por: Vieira, Jorge Alberto Menegasso, et al.
Publicado: (2023)

Use of Recombinant Activated Factor VII in Bleeding Lung Transplant Patients Undergoing Perioperative ECMO Therapy †
por: Laxar, Daniel, et al.
Publicado: (2023)

Calcium Repletion and Regional Citrate Anticoagulation in Hemodialysis and Hemodiafiltration: Using Dialysate Calcium to Modify Hypocalcemia
por: Dorie, Justin R., et al.
Publicado: (2021)

Regional citrate anticoagulation versus systemic heparin anticoagulation for continuous kidney replacement therapy in intensive care
por: Doidge, James C., et al.
Publicado: (2023)

Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study
por: Schultheiß, Caroline, et al.
Publicado: (2012)

Modified regional citrate anticoagulation is optimal for hemodialysis in patients at high risk of bleeding: a prospective randomized study of three anticoagulation strategies
por: Lin, Ting, et al.
Publicado: (2019)

Intermittent versus continuous enoxaparine for anticoagulation during continuous venovenous hemofiltration
por: Koroljov, A, et al.
Publicado: (2008)

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
por: Inchiosa, Mario A., et al.
Publicado: (2012)

Risk of Clinically Relevant Venous Thromboembolism in Critically Ill Patients With COVID-19: A Systematic Review and Meta-Analysis
por: Gratz, Johannes, et al.
Publicado: (2021)

Assay validity of point-of-care platelet function tests in thrombocytopenic blood samples
por: Lacom, Conrad, et al.
Publicado: (2022)

Regional citrate anticoagulation in hemodialysis: an observational study of safety, efficacy, and effect on calcium balance during routine care
por: Singer, Richard F., et al.
Publicado: (2016)

A simplified protocol for individualized regional citrate anticoagulation for hemodialysis: A single-center, randomized clinical study
por: Luo, Laimin, et al.
Publicado: (2021)

An Observational Cohort Study of the 2-Month Use of Regional Citrate Anticoagulation in Maintenance Hemodialysis Patients with Cerebral Hemorrhage
por: Bi, Xiao, et al.
Publicado: (2021)

Safety of Citrate Anticoagulation in CKRT: Monocentric Experience of a Dynamic Protocol of Calcium Monitoring
por: Nalesso, Federico, et al.
Publicado: (2023)

External validation of the ProVent score for prognostication of 1-year mortality of critically ill patients with prolonged mechanical ventilation: a single-centre, retrospective observational study in Austria
por: Dibiasi, Christoph, et al.
Publicado: (2022)

A mode of CVVH with regional citrate anticoagulation compared to no anticoagulation for acute kidney injury patients at high risk of bleeding
por: Gao, Jianping, et al.
Publicado: (2019)

Citrate Anticoagulation for CRRT in Children: Comparison with Heparin
por: Fernández, Sara Nicole, et al.
Publicado: (2014)

Complications of regional citrate anticoagulation: accumulation or overload?
por: Schneider, Antoine G., et al.
Publicado: (2017)

Prophylactic anticoagulation with low dose enoxaparin: is the subcutaneous route appropriate in the critically ill?
por: Priglinger, U, et al.
Publicado: (2002)

Comparative Studies on the Anticoagulant Profile of Branded Enoxaparin and a New Biosimilar Version
por: Qneibi, Dalia, et al.
Publicado: (2020)

Citrate pharmacokinetics and calcium levels during high-flux dialysis with regional citrate anticoagulation
por: Kozik-Jaromin, Justyna, et al.
Publicado: (2009)

Comparison between regional citrate anticoagulation and heparin for intermittent hemodialysis in ICU patients: a propensity score-matched cohort study
por: Leroy, Christophe, et al.
Publicado: (2021)

Enoxaparin as an Anticoagulant in a Multipara with a Mechanical Mitral Valve: A Case Report
por: Lee, Yo Seb, et al.
Publicado: (2023)

Simplified Citrate Anticoagulation for CRRT Without Calcium Replacement
por: Broman, Marcus, et al.
Publicado: (2015)

Simple citrate anticoagulation protocol for low flux haemodialysis
por: Lim, Eng Kuang, et al.
Publicado: (2018)

Impact of anion exchange adsorbents on regional citrate anticoagulation
por: Strobl, Karin, et al.
Publicado: (2020)

A prospective study on serum citrate levels and clinical correlations in patients receiving regional citrate anticoagulation
por: To, Harmony H M, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9jnaf1qjg9fmle49bcq1lhv43r